Cargando…
Characteristics of patients with hepatocellular carcinoma: A multicenter study
BACKGROUND AND AIM: The aim of the present study was to examine the etiology of hepatocellular carcinoma (HCC) by underlying cause and determine the characteristics and clinical features of patients with HCC. MATERIALS AND METHODS: The study comprised 1802 HCC patients diagnosed and followed up by L...
Autores principales: | Guzelbulut, Fatih, Karaogullarindan, Umit, Akkiz, Hikmet, Altintas, Engin, Demirtas, Coskun Ozer, Bahadir, Ozgur, Keklikkiran, Caglayan, Yildirim, Abdullah Emre, Gumussoy, Mesut, Balci, Hatice Rizaoglu, Gokcen, Pinar, Gokce, Dilara Turan, Simsek, Cem, Turan, Ilker, Can, Guray, Gokbulut, Volkan, Yaras, Serkan, Adali, Gupse, Akdogan, Remzi Adnan, Avcioglu, Ufuk, Demir, Mehmet, Doganay, Hamdi Levent, Vatansever, Sezgin, Sumer, Hale, Dilber, Feyza, Kayhan, Meral Akdogan, Balaban, Hatice Yasemin, Simsek, Halis, Ozdogan, Osman Cavit, Akarca, Ulus Salih, Karasu, Zeki, Gunsar, Fulya, Idilman, Ramazan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kare Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510736/ https://www.ncbi.nlm.nih.gov/pubmed/36177097 http://dx.doi.org/10.14744/hf.2022.2022.0028 |
Ejemplares similares
-
The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort
por: Yaras, Serkan, et al.
Publicado: (2023) -
Significance of detectable hepatitis B virus DNA in liver allograft tissue in long-term follow-up of liver transplant recipients
por: Mut Surmeli, Deniz, et al.
Publicado: (2021) -
Psychometric tests, critical flicker frequency, and inflammatory indicators in covert hepatic encephalopathy diagnosis
por: Demirciler, Erkut, et al.
Publicado: (2023) -
Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?
por: Adali, Gupse, et al.
Publicado: (2021) -
Predictive value of FibroScan in detecting liver fibrosis in HBeAg negative patients with chronic hepatitis B whose HBV DNA 2000–20000 IU/ml with ALT 1–2 times the upper limit of normal and those with HBV DNA >20000 IU/ml and normal ALT
por: Danis, Nilay, et al.
Publicado: (2021)